By, Rajesh Dave, MD Despite innovation in stents, balloons, adjunctive devices, etc. the mortality in cardiogenic shock remains around 50% in…
One month ago we kicked-off C3 2018 to a record-breaking attendance. Our outstanding faculty had such an amazing educational program…
By Rajesh Dave I was the fortunate physician who had the privilege of performing the very first commercially approved Sapien…
By Bryan Kluck, DO, FSCAI Being a Course Co-Director for C3 has been a spectacular experience. This conference has…
Issue of Debate at C3, June 17-20, 2018 Interventional Academy Speaks with Prof David Erlinge, MD, PhD, FESC, FACC, Head,…
Interventional Academy Speaks to William Fearon, MD and Bernard DeBruyne, MD With keen interest, I read the study by Kang…
TREAT: Are we one step closer? by Rajesh M. Dave, MD It is well established that Primary PCI in a timely…
Update on ODYSSEY Outcomes – by Dr. Rajesh Dave, MD, FSCAI, FACC ODYSSEY Outcomes, the second of the cardiovascular outcomes…
By, Dr. Arasi Maran From struggling for our right to vote to now.. what an incredible journey it has been. Even…
Flu and Heart Attack Association in NEJM By Rajesh Dave, MD Data from CDC reports worst flu season in decade.…